Cargando…
Peptide aptamer targeting Aβ–PrP–Fyn axis reduces Alzheimer’s disease pathologies in 5XFAD transgenic mouse model
Currently, no effective therapeutics exist for the treatment of incurable neurodegenerative diseases such as Alzheimer’s disease (AD). The cellular prion protein (PrP(C)) acts as a high-affinity receptor for amyloid beta oligomers (AβO), a main neurotoxic species mediating AD pathology. The interact...
Autores principales: | Ali, Tahir, Klein, Antonia N., Vu, Alex, Arifin, Maria I., Hannaoui, Samia, Gilch, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164677/ https://www.ncbi.nlm.nih.gov/pubmed/37149826 http://dx.doi.org/10.1007/s00018-023-04785-w |
Ejemplares similares
-
Propagation of PrP(Sc) in mice reveals impact of aggregate composition on prion disease pathogenesis
por: Chang, Sheng Chun, et al.
Publicado: (2023) -
Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP(C)
por: Corda, Erica, et al.
Publicado: (2018) -
Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation
por: Gilch, Sabine, et al.
Publicado: (2009) -
Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
por: Hannaoui, Samia, et al.
Publicado: (2014) -
Anti‐PrP(C) antibody rescues cognition and synapses in transgenic alzheimer mice
por: Cox, Timothy O., et al.
Publicado: (2019)